Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system.

Montgomery SL, Bowers WJ.

J Neuroimmune Pharmacol. 2012 Mar;7(1):42-59. doi: 10.1007/s11481-011-9287-2. Epub 2011 Jul 5. Review.

PMID:
21728035
[PubMed - indexed for MEDLINE]
2.

Death receptor signalling in central nervous system inflammation and demyelination.

Mc Guire C, Beyaert R, van Loo G.

Trends Neurosci. 2011 Dec;34(12):619-28. doi: 10.1016/j.tins.2011.09.002. Epub 2011 Oct 13. Review.

PMID:
21999927
[PubMed - indexed for MEDLINE]
3.

Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.

Frankola KA, Greig NH, Luo W, Tweedie D.

CNS Neurol Disord Drug Targets. 2011 May;10(3):391-403. Review.

PMID:
21288189
[PubMed - indexed for MEDLINE]
4.

Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.

Akassoglou K, Bauer J, Kassiotis G, Pasparakis M, Lassmann H, Kollias G, Probert L.

Am J Pathol. 1998 Sep;153(3):801-13.

PMID:
9736029
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The role of IL-15 in central nervous system disorders.

Rentzos M, Rombos A.

Acta Neurol Scand. 2012 Feb;125(2):77-82. doi: 10.1111/j.1600-0404.2011.01524.x. Epub 2011 May 26. Review.

PMID:
21615353
[PubMed - indexed for MEDLINE]
6.

TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease.

McCoy MK, Tansey MG.

J Neuroinflammation. 2008 Oct 17;5:45. doi: 10.1186/1742-2094-5-45. Review.

PMID:
18925972
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha.

Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G.

Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11294-8.

PMID:
7479982
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.

De Lella Ezcurra AL, Chertoff M, Ferrari C, Graciarena M, Pitossi F.

Neurobiol Dis. 2010 Mar;37(3):630-40. doi: 10.1016/j.nbd.2009.11.018. Epub 2009 Dec 5.

PMID:
19969084
[PubMed - indexed for MEDLINE]
9.

Amyloid-beta peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1.

Sutton ET, Thomas T, Bryant MW, Landon CS, Newton CA, Rhodin JA.

J Submicrosc Cytol Pathol. 1999 Jul;31(3):313-23.

PMID:
10626000
[PubMed - indexed for MEDLINE]
10.

Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB.

Taoufik E, Tseveleki V, Chu SY, Tselios T, Karin M, Lassmann H, Szymkowski DE, Probert L.

Brain. 2011 Sep;134(Pt 9):2722-35. doi: 10.1093/brain/awr203.

PMID:
21908876
[PubMed - indexed for MEDLINE]
Free Article
11.

Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?

Tansey MG, Frank-Cannon TC, McCoy MK, Lee JK, Martinez TN, McAlpine FE, Ruhn KA, Tran TA.

Front Biosci. 2008 Jan 1;13:709-17. Review.

PMID:
17981581
[PubMed - indexed for MEDLINE]
12.
13.

Tumor necrosis factor modulates transcription of myelin basic protein gene through nuclear factor kappa B in a human oligodendroglioma cell line.

Huang CJ, Nazarian R, Lee J, Zhao PM, Espinosa-Jeffrey A, de Vellis J.

Int J Dev Neurosci. 2002 Jun-Aug;20(3-5):289-96.

PMID:
12175864
[PubMed - indexed for MEDLINE]
14.

Glial expression of tumor necrosis factor in transgenic animals: how do these models reflect the "normal situation"?

Probert L, Akassoglou K.

Glia. 2001 Nov;36(2):212-9. Review.

PMID:
11596129
[PubMed - indexed for MEDLINE]
15.

Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction.

Park KM, Bowers WJ.

Cell Signal. 2010 Jul;22(7):977-83. doi: 10.1016/j.cellsig.2010.01.010. Epub 2010 Jan 21. Review.

PMID:
20096353
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

T-lymphocyte tumor necrosis factor-alpha receptor binding in patients with Parkinson's disease.

Bongioanni P, Castagna M, Maltinti S, Boccardi B, Dadone F.

J Neurol Sci. 1997 Jul;149(1):41-5.

PMID:
9168164
[PubMed - indexed for MEDLINE]
17.

Alpha-synuclein, Parkinson's disease, and Alzheimer's disease.

Kim S, Seo JH, Suh YH.

Parkinsonism Relat Disord. 2004 May;10 Suppl 1:S9-13. Review.

PMID:
15109581
[PubMed - indexed for MEDLINE]
18.

Divergent roles for tumor necrosis factor-alpha in the brain.

Sriram K, O'Callaghan JP.

J Neuroimmune Pharmacol. 2007 Jun;2(2):140-53. Epub 2007 Mar 31. Review.

PMID:
18040839
[PubMed - indexed for MEDLINE]
19.

Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.

Raine CS, Bonetti B, Cannella B.

Rev Neurol (Paris). 1998 Sep;154(8-9):577-85.

PMID:
9809372
[PubMed - indexed for MEDLINE]
20.

Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.

Reinhard C, Shamoon B, Shyamala V, Williams LT.

EMBO J. 1997 Mar 3;16(5):1080-92.

PMID:
9118946
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk